Blast Counts Not Enough to Distinguish MDS From AML, Experts Say Blast Counts Not Enough to Distinguish MDS From AML, Experts Say
Oncologists argue that in differentiating myelodysplastic syndrome from acute myeloid leukemia, more than just bone marrow blast cutoff should be considered.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Health | Hematology | Leukemia | Myelodysplastic Syndrome